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osting by EAbstract The purpose of the present study was to evaluate the transport of ascorbic acid, a water
soluble molecule, through a predominantly lipophilic cornea. Thus in-vitro permeation of ascorbic
acid from aqueous drops through freshly excised mammalian cornea was studied. Aqueous isotonic
ophthalmic solutions of ascorbic acid of different concentrations (0.125% w/v to 2% w/v) (pH 5.4)
were made. Further 1.0% w/v or 0.5% w/v ascorbic acid solution containing NaCl or dextrose as
tonicity modiﬁers or Na+K+-ATPase inhibitors were also made. Permeation characteristics of drug
were evaluated by putting 1 ml formulation on freshly excised cornea ﬁxed between donor and
receptor compartments of an all-glass modiﬁed Franz diffusion cell and measuring the drug perme-
ated in the receptor by spectrophotometry at 265 nm, after 120 min. Statistical analysis was done by
one-way analysis of variance (ANOVA) followed by Dunnett’s test or paired t-test. Increase in drug
concentration in the formulation resulted in an increase in the quantity permeated but after a cer-
tain level increase in permeation with increase in concentration was minimal. Aqueous drops made
isotonic with dextrose showed decreased permeation through paired cornea compared with aqueous, Samtanagar Road, Opposite
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166 S. Singla et al.drops made isotonic with NaCl from 1% w/v ascorbic acid solution suggesting likely involvement of
Na+ co-transporter but there was decreased permeation through 0.5% w/v ascorbic acid solution
made isotonic with NaCl as compared to solution made isotonic with dextrose. Further aqueous
drops containing Na+K+-ATPase inhibitor {MAG-Mono Ammonium Glycyrrhizinate (25 lmol)}
showed decreased corneal permeation from 0.5% w/v ascorbic acid solution but there was not sig-
niﬁcant decrease from 1% ascorbic acid solution since MAG is a competitive inhibitor of ascorbic
acid. Aqueous drops containing Na+K+-ATPase inhibitor {MAG (50 lmol) or Ouabain
(1 mmol)} showed decreased corneal permeation of ascorbic acid compared with control from
1% ascorbic acid solution conﬁrming the involvement of Na+ co-transporter.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Humans are unable to synthesize ascorbic acid, it is therefore
actively absorbed from the diet by sodium dependent transport
systems in the intestine (Liang et al., 2001). Ocular tissue accu-
mulates higher concentration of ascorbic acid than other tis-
sues, because ocular ascorbic acid being an antioxidant
defends the cornea & lens, against photo oxidative damage
(Maurice and Riley, 1970; Koskela et al., 1989; Bode et al.,
1991; Davies and Truscott, 2001; Valero et al., 2002).
Topical delivery into the conjuctival cul-de sac is by far the
most common route of ocular drug delivery. Absorption from
this site may be corneal or non corneal. The corneal absorp-
tion represents the major mechanism of absorption for most
therapeutic entities. The cornea is a trilaminate structure con-
sisting of three major diffusional barriers, epithelium, stroma
and endothelium (Prausnitz and Noonan, 1998; Mitra, 2003).
There are two general processes of drug absorption across bar-
rier membranes (Grass and Robinson, 1988; Grass et al.,
2006). The ﬁrst type is called ‘‘the transcellular transport pro-
cess,’’ where drug molecules have to go through the barrier
cells to reach the circulation. Transcellular transport is typi-
cally a two step process, starting with drug uptake into the
cells, and ending with drug efﬂux out of the cells. The second
type is called ‘‘the paracellular transport process,’’ where the
drug molecules travel between the cells (or in the gaps) to reach
the circulation (Prausnitz and Noonan, 1998). The mechanism
of transcellular transport includes simple diffusion, facilitated
diffusion, active transport, endocytosis and exocytosis.
Eyes are under continuous oxidative stress that can lead to
cataract. In case of cataract there is deﬁciency of ascorbic acid
in eye ﬂuid that can improve by increasing oral intake of ascor-
bic acid which is 60% and gets accumulated into eyes to pro-
tect it from oxidative stress, but at the same time chronic
intake of oral mega doses of ascorbic acid is known to cause
kidney stones (Lamden and Chrystowski, 1954; Briggs et al.,
1973; Hughes et al., 1981). To nullify this problem delivery
of ascorbic acid to eyes through cornea appears to be promis-
ing as compared to taking it orally. Transport of ascorbic acid,
a water soluble molecule, through a predominantly lipophilic
cornea offers a lot of challenge to the formulation chemist
(Mitra, 2003) and the same forms the basis of the study.
2. Materials and methods
Ascorbic acid (99.97% pure) was obtained from Ranbaxy
Laboratories (Gurgaon, India) as a gift sample. All other
chemicals like Sodium Chloride (Qualigens), Sodium Hydrox-ide (Rankem), Hydrochloric acid (CDH Pharma) and Sodium
bicarbonate (CDH Pharma) were also obtained. Mono
Ammonium Glycyrrhizinate was obtained from Curewell
Pharmaceutical (Faridabad) as gift sample & Ouabain Octahy-
drate (Sigma–Aldrich) obtained from National Institute of
Immunology, New Delhi. Fresh eyeballs of goat, sheep, and
buffalo were obtained from a local butcher shop (Ambedkar
Nagar, New Delhi, India) within 1 h of the animal’s slaughter-
ing. An all glass diffusion cell consisting of a receptor cell and
donor cell was used for permeation studies. The apparatus was
a modiﬁed version of the Franz diffusion cell as used by Mal-
hotra and Majumdar. The receptor cell had an internal volume
of 10 ml and side arm allowed sampling of receptor ﬂuid. The
donor cell was clamped onto the top of the receptor cell. Water
at 37 C was circulated through the water jacket surrounding
the receptor cell and Teﬂon coated magnetic stir bar kept at
the bottom of the receptor cell created a homogeneous recep-
tor volume (Malhotra and Majumdar, 1997).2.1. Method of permeation experiment
Freshly excised cornea was ﬁxed between clamped donor and
receptor compartments of an all-glass modiﬁed Franz diffusion
cell in such a way that its epithelial surface faced the donor com-
partment. The receptor compartment contained 10 ml freshly
prepared normal saline (pH 5.4), free from air bubbles. The cor-
neal area available for diffusion was 0.45 cm2. An aliquot (1 ml)
of aqueous drop formulation (freshly prepared ascorbic acid
solution) was placed on the cornea and the opening of the donor
cell was sealed with a glass cover slip; receptor ﬂuid was kept at
37 C with constant stirring using a Teﬂon coated magnetic stir
bead. Permeation studywas continued for 120 min, and samples
were withdrawn from receptor and analyzed for ascorbic acid
content by measuring absorbance at 265 nm in UV spectropho-
tometer (Shimadzu-1601, Kyoto, Japan). Results were ex-
pressed as amount permeated and percentage permeation or
in vitro ocular availability. The permeation (%) or in vitro ocu-
lar availability was calculated as follows:
Permeation (%) = (amount of drug permeated in receptor/
initial amount in donor) · 100
At the end of the experiment, each cornea (freed from
adhering sclera) was weighed, soaked in 1 ml methanol,
dried overnight at 90 C, reweighed. From the difference in
weights, corneal hydration was calculated. The permeation
characteristics of ascorbic acid from control and various for-
mulations were also evaluated through freshly excised paired
goat, sheep, and buffalo corneas.
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All solutions were made in distilled water and pH was adjusted
to 5.4 with 1 N NaHCO3 and 0.01 N HCl solution using pH
meter (Control Dynamics).
2.2.1. Ascorbic acid ophthalmic solutions of different
concentration
The required amount of ascorbic acid was dissolved in a sufﬁ-
cient amount of distilled water, sodium chloride was added to
make the ﬁnal solution isotonic, the pH of the solution was ad-
justed to 5.4 using 1 N NaHCO3 and 0.1 N HCl, and distilled
water was added as needed to bring the ﬁnal volume up to
50 ml, creating solutions of 0.125%w/v (7.097 mmol),
0.25%w/v (mmol), 0.5%w/v (23.39 mmol), 75%w/v (42.58
mmol), 1%w/v (56.779 mmol), 1.25%w/v (70.974 mmol),
1.5%w/v (85.1692 mmol), and 2%w/v (113.56 mmol)
concentration.
2.2.2. Ascorbic acid ophthalmic solutions (1% w/v or 0.5% w/v)
containing different isotonicity modiﬁers
Ascorbic acid (1gm or 0.5 gm) was dissolved in sufﬁcient
amount of distilled water & made up the volume of ﬁnal solu-
tion 50 ml with distilled water. One half of the solution was
made isotonic with dextrose & other with NaCl, the pH of
the solution was adjusted to 5.4 using 1 N NaHCO3 and0.1 N HCl, and distilled water was added as needed to bring
the ﬁnal volume up to 50 ml, creating solutions having differ-
ent tonicity modiﬁers.
2.2.3. Ascorbic acid ophthalmic solutions (1% w/v or0.5% w/v)
containing various Na+K+-ATPase inhibitors
\Ascorbic acid was dissolved in sufﬁcient amount of distilled
water, sodium chloride was added to make the ﬁnal solution
isotonic & make up the volume of solution of 50 ml with
distilled water. To one half of the solution Mono Ammo-
nium Glycyrrhizinate (MAG) (Na+K+-ATPase inhibitor)
(50 mmol or 50 mmol) or ouabain (1 mmol) was added,
pH of the solution was adjusted to 5.4 and distilled water
was added as needed to bring the ﬁnal volume up to
50 ml, creating solutions containing various Na+K+-ATPase
inhibitors.
2.2.4. Receptor media
For receptor media 0.9%NaCl solution having a pH of 5.4 was
prepared. The adjustment of pH was done with 0.01 N HCl.
2.3. Statistical analysis
Statistical analyses were done by one-way ANOVA followed by
Dunnett’s test. A paired t-test was used for studies with
paired corneas. P value <0.05 was considered signiﬁcant.
168 S. Singla et al.3. Results
Permeation results of ascorbic acid through freshly excised
goat cornea from solutions of different concentration were
shown in Table 1. In the concentration range of 0.125–
0.75% w/v there was a linear increase in permeation through
excised goat cornea. As the concentration was increased to
1%, there was a further increase in permeation. Further in-
crease in concentration did not increase permeation signiﬁ-
cantly. Normal cornea has a hydration level of 75–80%
(Maurice, 1971; Davies and Truscott, 2001). Corneal hydra-
tion observed in the present experiments was between 76 to
78%, indicating no damage to cornea.
To ascertain Na+ dependency of the transport of ascorbic
acid 0.5% w/v (23.39 mmol) or 1% w/v (56.78 mmol) solution
was made isotonic either with NaCl or dextrose. The pH was
adjusted to 5.4 as before. The study was conducted with paired
goat corneas i.e. one cornea of an animal received formulation
made isotonic with sodium chloride while the contra lateral
cornea received formulation made isotonic with dextrose.Table 1 Permeation of ascorbic acid through freshly excised goa
mean ± SEM.
Concentration (w/v) Amount Permeated (mg) (120 min)
0.125% (7.097 mmol) 0.014 ± 0.001
0.25% (14.19 mmol) 0.021 ± 0.001
0.5% (23.39 mmol) 0.03 ± 0.002
0.75% (42.58 mmol) 0.05 ± 0.003
1.0% (56.78 mmol) 0.089 ± 0.003
1.25% (70.974 mmol) 0.099 ± 0.01
1.5% (85.17 mmol) 0.104 ± 0.003
2.0% (113.56 mmol) 0.104 ± 0.001
 Statistically signiﬁcant (P< 0.05) compared with solution of 0.125% c
nett’s test.
Table 2 Permeation of ascorbic acid through freshly excised goa







0.50% NaCl* 0.025 ±
Dextrose 0.035 ±
1.0% NaCl* 0.075 ±
Dextrose 0.048 ±
 Statistically signiﬁcant (P< 0.05) compared with solution containing N
Table 3 Permeation of ascorbic acid through freshly excised goat,
with NaCl or Dextrose. Values are mean ± SEM of 3 corneas in ea
Cornea Tonicity adjusting substances Amount permeated (mg)
Goat NaCl* 0.075 ± 0.01
Dextrose 0.048 ± 0.006
Sheep NaCl* 0.059 ± 0.007
Dextrose 0.043 ± 0.005
Buﬀalo NaCl* 0.027 ± 0.0
Dextrose 0.013 ± 0.0
 Statistically signiﬁcant (P< 0.05) compared with solution containing NPermeation results (Table 2) showed increase in transport of
ascorbic acid in presence of dextrose from 0.5% w/v
(23.39 mmol) ascorbic acid solution indicating involvement
of GLUT transporter. However with 1% w/v solution of
ascorbic acid there was increase in permeation in the presence
of NaCl. Corneal hydration remained in the normal range.
To ascertain the role of Na+ co-transporters in the trans-
port of ascorbic acid from 1% w/v solution, the experiment
was repeated using paired corneas of sheep & buffalo. The re-
sults (Table 3) indicate marked reduction in permeation of
ascorbic acid in the presence of dextrose in both the corneas
similar to goat cornea. Corneal hydration remained in the nor-
mal range 76–78% indicating no damage to cornea.
To conﬁrm the involvement of Na+ in the transport of
ascorbic acid, ascorbic acid 0.5% w/v (23.39 mmol) or 1%
w/v (56.78 mmol) solution (pH 5.4, tonicity adjusted with so-
dium chloride) containing 25 lmol of MAG (competitive
Na+–K+ ATPase inhibitor) was made, and permeation study
was conducted with paired goat corneas i.e. one cornea of an
animal received formulation containing MAG (25 lmol) while
the contra lateral cornea received formulation without MAGt cornea from solutions of different concentration. Values are
Permeation (%) (120 min) Corneal Hydration (%)
1.12 78.54 ± 0.65
0.83 78.55 ± 1.1
0.65 76.69 ± 0.83
0.62 78.53 ± 0.76
0.89 76.61 ± 0.76
0.79 77.2 ± 1.1
0.69 78.5 ± 0.70
0.52 77.79 ± 0.86
oncentration as determined by one-way ANOVA followed by Dun-







0.004 0.5 75.04 ± 2.8
0.01 0.98 77.22 ± 2.1
0.01 0.75 78.54 ± 0.621
0.006 0.35 78.15 ± 0.31
aCl as determined by paired t-test.
sheep and buffalo cornea (paired) from solutions made isotonic
ch group.
(120 min) Permeation (%) (120 min) Corneal hydration (%)
0.75 78.54 ± 0.621
0.35 78.15 ± 0.31
0.59 77.58 ± 0.37
0.43 78.77 ± 0.42
0.27 75.44 ± 0.26
0.13 76.32 ± 0.56
aCl as determined by paired t-test.
Table 4 Permeation of ascorbic acid through freshly excised goat cornea (paired) from the solution containing MAG (Na+–K+
ATPase inhibitor, 25 lmol). Values are mean ± SEM of 3 corneas in each group.
Concentration (w/v) Amount permeated
(mg) (120 min)
Permeation (%) Corneal hydration (%)
0.50% Control 0.06 ± 0.008 1.18 76.48 ± 0.48
MAG 0.04 ± 0.01 0.85 76.39 ± 1.33
1.0% Control 0.09 ± 0.001 0.86 77.95 ± 1.66
MAG 0.08 ± 0.00 0.82 78.25 ± 1.62
 Statistically signiﬁcant (P< 0.05) compared with solution without MAG (control) as determined by paired t-test.
Table 5 Permeation of ascorbic acid through freshly excised goat cornea (paired) from solution containing MAG (Na+–K+ ATPase
inhibitor, 50 lmol) or Ouabain (Na+–K+ ATPase inhibitor, 1 mmol). Values are mean ± SEM of 3 corneas in each group.





1.0% Control 0.087 ± 0.006 0.87 78.65 ± 1.46
MAG* 0.047 ± 0.003 0.47 77.15 ± 1.52
1.0% Control 0.11 ± 0.017 1.1 79.64 ± 1.34
Quabain 0.066 ± 0.003 0.66 75.69 ± 1.67
 Statistically signiﬁcant (P< 0.05) compared with solution without MAG or without Ouabain (control) as determined by paired t-test.
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permeation of ascorbic acid from 0.5% w/v solution but there
was no reduction in permeation from 1% w/v ascorbic acid
solution. Further MAG concentration was increased from 25
to 50 lmol. Permeation studies with paired goat cornea (Table
5) showed that permeation of ascorbic acid was almost halved
in the presence of MAG (50 lmol). When the experiment was
repeated using Ouabain, a more speciﬁc Na+–K+ ATPase
inhibitor, similar inhibition on permeation of ascorbic acid
was observed.
4. Discussion
Rabbit corneal epithelium has been reported to contain Na+
transporters for ascorbic acid uptake (Bode et al., 1991; Talluri
et al., 2006). The present study indicates, that from 1% w/v
solution of ascorbic acid there was increase in permeation
through goat cornea in presence of NaCl as compared to solu-
tion made isotonic with dextrose, suggesting likely the involve-
ment of Na+ co-transporters. There was a marked reduction
in permeation of ascorbic acid in presence of dextrose in both
sheep and buffalo corneas similar to goat cornea suggesting
contribution of Na+ co-transporters. Liang et al. (2001) stud-
ied that cellular uptake of ascorbic acid mediated by Na+
dependent ascorbic acid transporters (SVCT1 and SVCT2)
that was further conﬁrmed by Subramaniam et al. (2008).
Since MAG is a competitive inhibitor, with increase in ascor-
bic acid concentration up to 1% w/v, the inhibitive effect on
permeation could be decreased (Cooperstein, 1987; Song,
2002). The present study suggests, with increase in MAG con-
centration there was increased inhibitive effect on permeation
of ascorbic acid from 1% solution through goat cornea and
the same found with ouabain. Thus the study supports the
involvement of Na+ transporters in ascorbic acid transport.
Corneal hydration remained in the normal range which
indicated no damage to cornea.5. Conclusion
Talluri et al. (2006) showed the involvement of Na+ depen-
dent transporter in the transport of ascorbic acid through
rabbit cornea. Our ﬁnding suggests that the presence of
Na+ dependent transporters in the cornea of goat, sheep
and buffalo could be responsible for transport of ascorbic
acid at low concentration. However further studies are
needed to consolidate the fact.References
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